PDGF-C and PDGF-D in ocular diseases
Authors:
- 1 August 2018
- journal article
- review article
- Published by Elsevier in Molecular Aspects of Medicine
- Vol. 62, 33-43
Abstract
No abstract availableKeywords
Funding Information
- State Key Laboratory of Ophthalmology (SKLO)
- Zhongshan Ophthalmic Center (ZOC)
- Sun Yat-Sen University (SYSU), Guangzhou, China
- National Natural Science Foundation of China (NSFC (81330021, 81670855)
- NSFC-Swedish Research Foundation (VR) International Collaboration (81611130082)
- Guangdong Province Leading Expert Program
This publication has 149 references indexed in Scilit:
- A Novel Strategy to Develop Therapeutic Approaches to Prevent Proliferative VitreoretinopathyThe American Journal of Pathology, 2011
- PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targetsProceedings of the National Academy of Sciences, 2010
- Platelet-derived Growth Factor-DD Targeting Arrests Pathological Angiogenesis by Modulating Glycogen Synthase Kinase-3β PhosphorylationJournal of Biological Chemistry, 2010
- Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3β phosphorylationJournal of Experimental Medicine, 2010
- PDGF receptors are activated in human epiretinal membranesExperimental Eye Research, 2009
- Role of platelet-derived growth factors in physiology and medicineGenes & Development, 2008
- Focus on Molecules: Platelet-derived growth factor C, PDGF-CExperimental Eye Research, 2008
- Perspective on Genes and Mutations Causing Retinitis PigmentosaArchives of Ophthalmology (1950), 2007
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- The Prevalence of Age-Related Macular Degeneration and Associated Risk FactorsArchives of Ophthalmology (1950), 2001